Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
Authors
Keywords
-
Journal
United European Gastroenterology Journal
Volume 8, Issue 1, Pages 91-98
Publisher
SAGE Publications
Online
2019-12-13
DOI
10.1177/2050640619895361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can IL-23 be a good target for ulcerative colitis?
- (2018) Mariangela Allocca et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study
- (2018) Levente Parragi et al. Journal of Crohns & Colitis
- Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
- (2018) Timo Rath et al. Frontiers in Immunology
- IL-23 in inflammatory bowel diseases and colon cancer
- (2018) Markus F. Neurath CYTOKINE & GROWTH FACTOR REVIEWS
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunopathogenesis of IBD: current state of the art
- (2015) Heitor S. P. de Souza et al. Nature Reviews Gastroenterology & Hepatology
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study
- (2011) M. Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
- (2011) Alessandra Geremia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-23/Th17 pathways and inflammatory bowel disease
- (2009) Clara Abraham et al. INFLAMMATORY BOWEL DISEASES
- Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
- (2009) Melanie A. Kleinschek et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now